Literature DB >> 18074159

A neonatal encephalopathy with seizures in standard poodle dogs with a missense mutation in the canine ortholog of ATF2.

Xuhua Chen1, Gary S Johnson, Robert D Schnabel, Jeremy F Taylor, Gayle C Johnson, Heidi G Parker, Edward E Patterson, Martin L Katz, Tomoyuki Awano, Shahwanaz Khan, Dennis P O'Brien.   

Abstract

Neonatal encephalopathy with seizures (NEWS) is a previously undescribed autosomal recessive disease of standard poodle puppies. Affected puppies are small and weak at birth. Many die in their first week of life. Those surviving past 1 week develop ataxia, a whole-body tremor, and, by 4 to 6 weeks of age, severe generalized clonic-tonic seizures. None have survived to 7 weeks of age. Cerebella from affected puppies were reduced in size and often contained dysplastic foci consisting of clusters of intermixed granule and Purkinje neurons. We used deoxyribonucleic acid samples from related standard poodles to map the NEWS locus to a 2.87-Mb segment of CFA36, which contains the canine ortholog of ATF2. This gene encodes activating transcription factor 2 (ATF-2), which participates in the cellular responses to a wide variety of stimuli. We amplified and sequenced all coding regions of canine ATF2 from a NEWS-affected puppy and identified a T > G transversion that predicts a methionine-to-arginine missense mutation at amino acid position 51. Methionine-51 lies within a hydrophobic docking site for mitogen-activated protein kinases that activate ATF-2 so the arginine substitution is likely to interfere with ATF-2 activation. All 20 NEWS-affected puppies in the standard poodle family were homozygous for the mutant G allele. The 58 clinically normal family members were either G/T heterozygotes or homozygous for the ancestral T allele. There are no previous reports of spontaneous ATF2 mutations in people or animals; however, atf2-knockout mice have cerebellar lesions that are similar to those in puppies with NEWS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18074159     DOI: 10.1007/s10048-007-0112-2

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  39 in total

1.  Mechanisms of MAPK signalling specificity.

Authors:  L Bardwell
Journal:  Biochem Soc Trans       Date:  2006-11       Impact factor: 5.407

2.  Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics.

Authors:  E Sobel; K Lange
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

3.  The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair.

Authors:  Jun Hayakawa; Chantal Depatie; Masahide Ohmichi; Dan Mercola
Journal:  J Biol Chem       Date:  2003-03-27       Impact factor: 5.157

4.  c-Jun NH(2)-terminal kinase is essential for the regulation of AP-1 by tumor necrosis factor.

Authors:  Juan-Jose Ventura; Norman J Kennedy; Jennifer A Lamb; Richard A Flavell; Roger J Davis
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

5.  A mutation in the CLN8 gene in English Setter dogs with neuronal ceroid-lipofuscinosis.

Authors:  Martin L Katz; Shahnawaz Khan; Tomoyuki Awano; S Adam Shahid; Aristotle N Siakotos; Gary S Johnson
Journal:  Biochem Biophys Res Commun       Date:  2005-02-11       Impact factor: 3.575

6.  Human non-synonymous SNPs: server and survey.

Authors:  Vasily Ramensky; Peer Bork; Shamil Sunyaev
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

7.  ATF-2 phosphorylation in apoptotic neuronal death.

Authors:  M Walton; A M Woodgate; E Sirimanne; P Gluckman; M Dragunow
Journal:  Brain Res Mol Brain Res       Date:  1998-12-10

8.  p38MAPK acts in the BMP7-dependent stimulatory pathway during epithelial cell morphogenesis and is regulated by Smad1.

Authors:  Ming Chang Hu; David Wasserman; Sunny Hartwig; Norman D Rosenblum
Journal:  J Biol Chem       Date:  2004-01-12       Impact factor: 5.157

9.  Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice.

Authors:  A M Reimold; M J Grusby; B Kosaras; J W Fries; R Mori; S Maniwa; I M Clauss; T Collins; R L Sidman; M J Glimcher; L H Glimcher
Journal:  Nature       Date:  1996-01-18       Impact factor: 49.962

10.  Smads, TAK1, and their common target ATF-2 play a critical role in cardiomyocyte differentiation.

Authors:  K Monzen; Y Hiroi; S Kudoh; H Akazawa; T Oka; E Takimoto; D Hayashi; T Hosoda; M Kawabata; K Miyazono; S Ishii; Y Yazaki; R Nagai; I Komuro
Journal:  J Cell Biol       Date:  2001-05-14       Impact factor: 10.539

View more
  7 in total

Review 1.  Man's best friend becomes biology's best in show: genome analyses in the domestic dog.

Authors:  Heidi G Parker; Abigail L Shearin; Elaine A Ostrander
Journal:  Annu Rev Genet       Date:  2010       Impact factor: 16.830

Review 2.  ATF2, a paradigm of the multifaceted regulation of transcription factors in biology and disease.

Authors:  Gregory Watson; Ze'ev A Ronai; Eric Lau
Journal:  Pharmacol Res       Date:  2017-02-15       Impact factor: 7.658

3.  From caveman companion to medical innovator: genomic insights into the origin and evolution of domestic dogs.

Authors:  Heidi G Parker; Samuel F Gilbert
Journal:  Adv Genomics Genet       Date:  2015-06-12

Review 4.  Dogs as a Natural Animal Model of Epilepsy.

Authors:  Wolfgang Löscher
Journal:  Front Vet Sci       Date:  2022-06-22

5.  International Veterinary Epilepsy Task Force's current understanding of idiopathic epilepsy of genetic or suspected genetic origin in purebred dogs.

Authors:  Velia-Isabel Hülsmeyer; Andrea Fischer; Paul J J Mandigers; Luisa DeRisio; Mette Berendt; Clare Rusbridge; Sofie F M Bhatti; Akos Pakozdy; Edward E Patterson; Simon Platt; Rowena M A Packer; Holger A Volk
Journal:  BMC Vet Res       Date:  2015-08-28       Impact factor: 2.741

6.  Adeno-associated virus serotypes 9 and rh10 mediate strong neuronal transduction of the dog brain.

Authors:  G P Swain; M Prociuk; J H Bagel; P O'Donnell; K Berger; K Drobatz; B L Gurda; M E Haskins; M S Sands; C H Vite
Journal:  Gene Ther       Date:  2013-10-17       Impact factor: 5.250

Review 7.  DNA testing in neurologic diseases.

Authors:  D P O'Brien; T Leeb
Journal:  J Vet Intern Med       Date:  2014-06-24       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.